Carbon-14 labeling of Saxagliptin (BMS-477118)

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 50, Issue 13, 2007, Pages 1224-1229

  Cao, Kai ^a   Bonacorsi, Samuel J ^a   Balasubramanian, Balu ^a   Hanson, Ronald L ^a   Manchand, Percy ^a   Godfrey, Jollie D ^a   Fox, Rita ^a   Christopher, Lisa J ^a   Su, Hong ^a   Iyer, Ramaswamy ^a  

^a BRISTOL MYERS SQUIBB RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Carbon 14 synthesis; Dpp iv inhibitor; Saxagliptin

Indexed keywords

CARBON; CHLORINE COMPOUNDS; IRON COMPOUNDS; ORGANOMETALLICS;

BIS(DIPHENYLPHOSPHINO) FERROCENE; CARBON 14; CARBON-14 SYNTHESIS; DPP-IV INHIBITOR; EFFICIENT SYNTHESIS; LABELINGS; OXALYL CHLORIDE; SAXAGLIPTIN; STEP SEQUENCES; SYNTHESISED;

AMINO ACIDS;

BROMINE DERIVATIVE; CARBON 14; CHLORIDE; PALLADIUM; SAXAGLIPTIN;

ARTICLE; CATALYSIS; CENTRIFUGATION; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; ISOTOPE LABELING;

EID: 38949174287     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1450     Document Type: Article

References (20)

1. (a) Knudsen LB. J Med Chem 2004; 47: 4128-4134;
2. (b) Weber AE. J Med Chem 2004; 47: 4135-4141;
3. (c) Reimer MK, Holst JJ, Ahrén B. Eur J Endocrinol 2002; 146: 717-727;
4. (d) Pospisilik JA, Stafford SG, Demuth H-U, Brownsey R, Parkhouse W, Finegood DT, McIntosh CHS, Pederson RA. Diabetes 2002; 51: 943-950;
5. (e) Pospisilik JA, Martin J, Doty T, Ehses JA, Pamir N, Lynn FC, Piteau S, Demuth H-U, McIntosh CHS, Pederson RA. Diabetes 2003; 52: 741-750.
6. (a) Holst JJ. Diabetologia 2006; 49: 253-260;
7. (b) Brubaker PL, Drucker DJ. Endocrinology 2004; 145: 2653-2659;
8. (c) Holst JJ. Horm Metab Res 2004; 36: 747-754.
9. Kim YB, Kopcho LM, Kirby MS, Hamann LG, Weigelt CA, Metzler WJ, Marcinkeviciene J. Arch Biochem Biophys 2006; 445: 9-18.
10. Augeri DJ, Robl JA, Betebenner DA, Magnin DR, Khanna A, Robertson JG, Wang A, Simpkins LM, Taunk P, Huang Q, Han S-P, Abboa-Offei B, Cap M, Xin L, Tao L, Tozzo E, Welzel GE, Egan DM, Marcinkeviciene J, Chang SY, Biller SA, Kirby MS, Parker RA, Hamann LG. J Med Chem 2005; 48: 5025-5037.
11. Vu TC, Brzozowski DB, Fox R, Godfrey Jr JD, Hanson RL, Kolotuchin SV, Mazzullo Jr JA, Patel RN, Wang J, Wong K, Yu J, Zhu J, Magnin DR, Augeri DJ, Hamann LG. Preparation of cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV. PCT Int Appl 2004; 101. CODEN: PIXXD2 WO 2004052850 A2 20040624 CAN 141:54618 AN 2004:515478 CAPLUS.
12. Hanson RL, Goldberg SL, Brzozowski DB, Tully TP, Cazzulino D, Parker WL, Lyngberg OK, Vu TC, Wong MK, Patel RN. Adv Synth Catal 2007; 349: 1369-1378.
13. (a) Kraus GA, Siclovan TM. J Org Chem 1994; 59: 922-923;
14. (b) Kim S-H, Hanson MV, Rieke RD. Tetrahedron Lett 1996; 37: 2197-2200;
15. (c) Rieke RD, Hanson MV, Brown JD, Niu QJ. J Org Chem 1996; 61: 2726-2730;
16. (d) Hanson MV, Brown JD, Rieke RD, Niu QJ. Tetrahedron Lett 1994; 35: 7205-7208.
17. Creay X. J Org Chem 1987; 52: 5026-5030.
18. Dieter RK, Sharma RR, Yu H, Gore VK. Tetrahedron 2003; 59: 1083-1094.
19. Maeda H, Hino N, Yamauchi Y, Ohmori H. Chem Pharm Bull 2000; 48: 1196-1199.
20. Rossi R, Carpita A, Pazzi P, Mannina L, Valensin D. Tetrahedron 1999; 55: 11343-11364.